EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis

研究成果: Article同行評審

9 引文 斯高帕斯(Scopus)

指紋

深入研究「EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis」主題。共同形成了獨特的指紋。

Medicine & Life Sciences